What is the definition of nephrotic-range proteinuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Nephrotic-Range Proteinuria

Nephrotic-range proteinuria is defined as ≥3.5 g/24 hours (or protein-to-creatinine ratio ≥3,500 mg/g) in adults, and ≥40 mg/m²/hour (or spot urine protein-to-creatinine ratio ≥2 g/g) in children. 1, 2

Standard Adult Thresholds

The following measurements all define nephrotic-range proteinuria in adults:

  • 24-hour urine collection: ≥3.5 g/24 hours (≥3,500 mg/day) 1, 3
  • Spot urine protein-to-creatinine ratio (PCR): ≥3,500 mg/g (≥3.5 g/g) 1
  • Albumin-specific measurements: Albumin excretion rate ≥2,200 mg/day or albumin-to-creatinine ratio ≥2,200 mg/g 1, 3

The albumin thresholds are lower than total protein thresholds because albumin comprises approximately 60-70% of total urinary protein in nephrotic syndrome. 3

Pediatric Thresholds

Children require body surface area adjustment with different measurement approaches:

  • Timed urine collection: ≥40 mg/m²/hour 1, 2, 4
  • First morning spot urine PCR: ≥2 g/g (≥2,000 mg/g) 1, 2
  • Urine dipstick: 3+ protein or greater 4

The spot urine PCR has replaced 24-hour collections as standard of care in children due to good correlation and practical advantages. 2

Critical Distinction: Proteinuria vs. Syndrome

Nephrotic-range proteinuria alone does NOT equal nephrotic syndrome. 1, 2

Full nephrotic syndrome requires the complete triad:

  • Proteinuria ≥3.5 g/24 hours (adults) or ≥40 mg/m²/hour (children) 2, 5
  • Serum albumin <3.0 g/dL in adults or ≤2.5 g/dL in children 1, 2, 4
  • Edema 1, 5

Additional features often present include hyperlipidemia and increased thromboembolism risk, but these are not required for diagnosis. 5

Important Clinical Caveats

Albumin assay variability matters clinically: A serum albumin of 2.5 g/dL measured by BCG method equals approximately 2.0 g/dL by BCP method. 2

Exceptions to the 3.5 g/day threshold exist: Patients with concurrent liver disease (such as hepatic amyloidosis) may present with full nephrotic syndrome despite proteinuria <3.5 g/24 hours because reduced hepatic albumin synthesis allows a steady state to be reached at lower protein excretion levels. 6 In these cases, the diagnosis relies on demonstrating severe glomerular permeability defects despite lower absolute proteinuria values.

Prognostic Significance

The degree of proteinuria carries major prognostic implications:

  • Proteinuria >3.8 g/day: 35% risk of end-stage renal disease within 2 years 1, 2
  • Proteinuria <2.0 g/day: Only 4% risk of end-stage renal disease within 2 years 1, 2

Terminology Update

KDIGO classification no longer uses "nephrotic-range" terminology for staging albuminuria, instead using "A3 (Severely Increased Albuminuria)" for ACR ≥300 mg/g. 1 However, the designation "nephrotic-range" remains clinically important when specifying whether full nephrotic syndrome is present. 1

References

Guideline

Nephrotic Range Proteinuria Definition and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nephrotic Syndrome Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nephrotic syndrome in diabetic kidney disease: an evaluation and update of the definition.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009

Research

Nephrotic syndrome in infants and children: pathophysiology and management.

Paediatrics and international child health, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.